Aleva Neurotherapeutics Funding: $70M Raised, Series E
Aleva Neurotherapeutics has raised $70M in total funding. Latest round: Series E. Backed by BB Biotech Ventures, Initiative Capital Romandie, Kinled Holding.
Aleva Neurotherapeutics funding overview
Aleva Neurotherapeutics has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series E announced in December 2019. The round record for Aleva Neurotherapeutics runs through 2019; nothing later has been disclosed. Investors on record include BB Biotech Ventures, Initiative Capital Romandie, Kinled Holding, BioMedPartners, Forrestal Capital, Kreaxi. 6 distinct backers are named across the disclosed rounds.
Frequently asked about Aleva Neurotherapeutics funding
How much has Aleva Neurotherapeutics raised?
Aleva Neurotherapeutics has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Aleva Neurotherapeutics?
BB Biotech Ventures, Initiative Capital Romandie, Kinled Holding, BioMedPartners, Forrestal Capital, Kreaxi are named among the investors backing Aleva Neurotherapeutics.
What was the latest Aleva Neurotherapeutics funding round?
The most recent disclosed round is a Series E, announced in December 2019.
Where is Aleva Neurotherapeutics based?
No headquarters location is disclosed for Aleva Neurotherapeutics.
When did Aleva Neurotherapeutics last raise?
The last disclosed Aleva Neurotherapeutics round closed in December 2019 at Series E.
Round data for Aleva Neurotherapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.
